NASDAQ:FTXH First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News → $9 AI Model with 90% Win Rate? (From Trade Machine) (Ad) Free FTXH Stock Alerts $27.17 -0.03 (-0.11%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$27.03▼$27.1750-Day Range$25.78▼$27.3452-Week Range$23.85▼$28.41Volume496 shsAverage Volume5,831 shsMarket Capitalization$20.38 millionAssets Under Management$20.39 millionDividend Yield1.40%Net Expense Ratio0.60% Stock AnalysisStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get First Trust Nasdaq Pharmaceuticals ETF alerts: Email Address About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Read More FTXH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTXH ETF News HeadlinesAugust 3, 2022 | stocknews.com3 Health Care ETFs You'll Want to Own When the Market RecoversMay 25, 2022 | nasdaq.comSurprising Analyst 12-Month Target For FTXHMarch 25, 2022 | seekingalpha.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488February 22, 2022 | nasdaq.comSolid Q4 Earnings Fail to Impress Pharma ETFsNovember 9, 2021 | nasdaq.comWave of Solid Q3 Earnings Push Pharma ETFs HigherAugust 19, 2021 | msn.com4 ETF Strategies to Follow Warren Buffett's VisionSee More Headlines Receive FTXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust Nasdaq Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FTXH Inception Date9/20/2016 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkNasdaq US Smart Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings51 Fund Statistics Assets Under Management$20.41 million Average Daily Volume$2,956.30 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest1,000 shs Miscellaneous Outstanding Shares750,000Beta0.70 Creation Unit50,000 Creation Fee$500.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad Trade MachinePotentially Pocket $767/Day with AIWhat if I told you it could take just $9… To win 90% of your options trades?Click here to see this revolutionary AI model in action… First Trust Nasdaq Pharmaceuticals ETF ExpensesTypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.60%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.54%-0.21%-0.56%Net Expense0.60%0.60%0.60%0.54%0.58% First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & ExposureTop 10 FTXH HoldingsPfizer(NYSE:PFE)Holding Weight: 7.95%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 7.52%AbbVie(NYSE:ABBV)Holding Weight: 7.02%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.65%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 5.90%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 4.23%Amgen(NASDAQ:AMGN)Holding Weight: 4.09%Eli Lilly and Company(NYSE:LLY)Holding Weight: 4.07%United Therapeutics(NASDAQ:UTHR)Holding Weight: 4.07%Biogen(NASDAQ:BIIB)Holding Weight: 3.92%FTXH Sector ExposureFTXH Industry ExposureFull Holdings Details Similar ETFsHorizon Kinetics Medical ETFNASDAQ:MEDXPrincipal Healthcare Innovators ETFNASDAQ:BTECInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInstitutional OwnershipAmeritas Investment Partners Inc.Bought 587 shares on 5/13/2024Ownership: 1.493%Janney Montgomery Scott LLCBought 36,764 shares on 5/1/2024Ownership: 4.902%View All Institutional Transactions FTXH ETF - Frequently Asked Questions How have FTXH shares performed in 2024? First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 at the beginning of 2024. Since then, FTXH shares have increased by 2.1% and is now trading at $27.17. View the best growth stocks for 2024 here. How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF? First Trust Nasdaq Pharmaceuticals ETF declared a dividend on Wednesday, March 20th. Shareholders of record on Friday, March 22nd will be given a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date is Thursday, March 21st. Read our dividend analysis for FTXH. What does FTXH invest in? First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $20.41 million assets under management. What stocks does First Trust Nasdaq Pharmaceuticals ETF hold? FTXH invests in 51 holdings. Some of the stocks in their portfolio include Pfizer (PFE), Merck & Co., Inc. (MRK), AbbVie (ABBV), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Vertex Pharmaceuticals (VRTX), Amgen (AMGN), Eli Lilly and Company (LLY), United Therapeutics (UTHR) and Biogen (BIIB). What is the management fee for First Trust Nasdaq Pharmaceuticals ETF? First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%. What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA). Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders? First Trust Nasdaq Pharmaceuticals ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Janney Montgomery Scott LLC (4.90%) and Ameritas Investment Partners Inc. (1.49%). How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF? Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTXH) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored$9 AI Model with 90% Win Rate?What if I told you it could take just $9… To win 90% of your options trades?Trade Machine | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.